3rd Party Biotechnology Industry News

Sanofi has dropped its respiratory syncytial virus vaccine for toddlers [...]

Ophthalmology biotech veteran Gregory Kunst has found his next venture [...]

Inhibrx Biosciences’ antibody ozekibart has notched a key phase 2 [...]

Regeneron has given up on a CAR-T candidate acquired from [...]

Ventyx Biosciences’ cardiovascular disease drug cut levels of a biomarker [...]

Roche has dropped five Chugai candidates from its clinical pipeline, [...]

Recorded at Fierce Biotech Week, this episode of “The Top [...]

Moderna is halting development of an mRNA vaccine for congenital [...]

In a mixed interim data drop, Arcturus Therapeutics has revealed [...]

Alector Therapeutics is shelving a GSK-partnered antibody after the asset [...]